Prevalence of Subclinical Systemic Lymphedema in Patients Following Treatment for Breast Cancer and Association with Body Mass Index

Godoy, José María Pereira de; Godoy, Lívia Maria Pereira de; Godoy, Maria de Fátima Guerreiro

doi:10.7759/cureus.7291

Cited by 5 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Obesity is another aggravating factor of lymphedema, but it can be the cause, so a series of factors must be analyzed in the differential diagnosis of lymphedema. 14 In daily clinical practice, the determination of primary or secondary lymphedema is fundamental to the definition of the therapeutic strategy. 1 Another aspect that defines the strategy is whether or not the lymphedema is hypertensive.…”

Section: Discussionmentioning

confidence: 99%

Epidemiological data on lower limb lymphedema

Pereira de Godoy,

Pereira de Godoy Capeletto,

Carolina Pereira de Godoy

et al. 2022

MOJBM

View full text Add to dashboard Cite

Objective: The aim of the present study was to evaluate epidemiological data of patients seen at a clinic specialized in the treatment of lymphedema. Methods: A retrospective, cross-sectional study was conducted involving data from 150 consecutive patients with lower limb lymphedema in clinical stages II and III treated at the Godoy Clinic in São Jose do Rio Preto. The follow data were collected: sex, age, type of lymphedema (primary or secondary), cause of secondary lymphedema (cancer, trauma, venous disease) and limb dominance. The diagnosis of lymphedema was based on the clinical history and physical examination; in cases of doubt, lymphoscintigraphy of the lower limbs was requested. Descriptive statistics were performed and results were expressed as percentages. Results: Twenty-five (16.66%) of the patients were male and 125 (83.33%) were female. Mean age was 42.52 years (41.8 years among the men and 42.67 years among the women). One hundred nine cases (72.66%) were primary lymphedema and 41 (27.33%) were secondary. Among the secondary cases, 27 (18%) were related to cancer treatment, 10 (6.6%) were linked to trauma and four (2.6%) were cases of phlebolymphedema. Mean age was 51.4 years among the patients with cancer treatment-related lymphedema, 41 years among those with trauma-related lymphedema and 64.25 years among those with phlebolymphedema. The left leg was affected in 61 cases (40.66%), the right leg was affected in 37 cases (24.66%) and lymphedema was bilateral in 52 cases (34.66%). Conclusion: Primary lymphedema was predominant and affected women more than men. Primary lymphedema occurred at an earlier age compared to cancer treatment-related lymphedema and phlebolymphedema. The left leg was affected more often, followed by bilateral lymphedema and, finally, the right leg alone.

show abstract

Section: Discussionmentioning

confidence: 99%

Epidemiological data on lower limb lymphedema

Pereira de Godoy,

Pereira de Godoy Capeletto,

Carolina Pereira de Godoy

et al. 2022

MOJBM

View full text Add to dashboard Cite

show abstract

“…Additional care is important, such as the control of obesity, pain, especially in women with lipedema, which are limiting factors and further reduce the quality of life of these patients [20][21][22][23]. The two main challenges in the treatment of BCRL are the normalization or near normalization of the edema and the maintenance of the results.…”

Section: Discussionmentioning

confidence: 99%

Intensive Treatment for Upper Limb Lymphedema

Godoy¹,

Godoy²,

Godoy³

et al. 2021

Cureus

Self Cite

View full text Add to dashboard Cite

show abstract

“…Several approaches to treatment for lower limb lymphedema have been reported in the literature. However, an intensive form of treatment, denominates Godoy Method®, proposes a reduction in the volume of the limb by approximately 50% in five days and reaching normality or near normality by the end of the first phase of treatment [10][11][12][13]. A variety of methods for limb volume evaluation are reported in the literature.…”

Section: Introductionmentioning

confidence: 99%

Multi-segment bioimpedance in the evaluation of treatment for secondary lower limb lymphedema: Gynecological cancer

Godoy

et al. 2023

ELECTRON J GEN MED

Self Cite

View full text Add to dashboard Cite

Aim: The present aimed study was to report the mobilization of body fluids after five days of intensive treatment for secondary lower limb lymphedema. Materials and methods: A crossover clinical trial was conducted involving the analysis of changes in intracellular and extracellular fluids in all extremities and the trunk in women with lower limb lymphedema secondary to treatment for gynecological cancer. Evaluations were performed with multi-segment bio impedance analysis before and after intensive treatment using Godoy Method® eight hours per day for five days. Comparisons were made using Wilcoxon signed-ranks test. Results: Significant changes in intracellular and extracellular fluids were found in all extremities and the trunk (p<0.0001 for all comparisons). Conclusion: Intensive Godoy Method® leads to important changes in the distribution of body fluids in the treatment of lower limb lymphedema following treatment for gynecological cancer, with a significant increase in fluids in the upper limbs and trunk as well as significant reductions in the lower limb and in intracellular and extracellular water.

show abstract

Prevalence of Subclinical Systemic Lymphedema in Patients Following Treatment for Breast Cancer and Association with Body Mass Index

Cited by 5 publications

References 10 publications

Epidemiological data on lower limb lymphedema

Epidemiological data on lower limb lymphedema

Intensive Treatment for Upper Limb Lymphedema

Multi-segment bioimpedance in the evaluation of treatment for secondary lower limb lymphedema: Gynecological cancer

Contact Info

Product

Resources

About